Company Filing History:
Years Active: 1998-2003
Title: The Innovative Contributions of Gemma Jodas Farres
Introduction
Gemma Jodas Farres is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable formulations for peptide compounds. With a total of three patents to her name, her work has the potential to impact medical treatments significantly.
Latest Patents
One of her latest patents is a stable pharmaceutical formulation for intravenous or intramuscular administration of active peptide compounds. This formulation is characterized by the inclusion of glycine in concentrations ranging from 10 to 60 mM and an aqueous solution of hydrochloric acid to adjust the pH to values between 3.0 and 4.2. Another notable patent is a procedure for obtaining the somatostatin analog, octreotide. This procedure involves solid-phase synthesis on polymer supports and the use of Fmoc/tBu type protecting groups. It details the construction of a seven amino acid linear peptide and the subsequent steps to obtain octreotide.
Career Highlights
Gemma Jodas Farres is currently associated with Lipotec, S.A., where she continues to innovate in her field. Her work has garnered attention for its potential applications in medical therapies, particularly in the treatment of various conditions requiring peptide-based medications.
Collaborations
She has collaborated with notable coworkers, including Berta Ponsati Obiols and Francisco Javier Clemente Rodriguez, contributing to a dynamic research environment that fosters innovation.
Conclusion
Gemma Jodas Farres exemplifies the spirit of innovation in the pharmaceutical industry. Her patents and ongoing work at Lipotec, S.A. highlight her commitment to advancing medical science through her inventive contributions.